5 medicines held by Sandoz Pharmaceuticals GmbH on the Irish market, from the HPRA register of authorised products.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Rivastigmine Sandoz 1.5 mg hard capsules EU/1/09/599/001-003 |
Rivastigmine hydrogen tartrate | Sandoz Pharmaceuticals GmbH | — |
| Rivastigmine Sandoz 2 mg/ml oral solution EU/1/09/599/017-018 |
Rivastigmine hydrogen tartrate | Sandoz Pharmaceuticals GmbH | — |
| Rivastigmine Sandoz 3 mg hard capsules EU/1/09/599/005-007 |
Rivastigmine hydrogen tartrate | Sandoz Pharmaceuticals GmbH | — |
| Rivastigmine Sandoz 4.5 mg hard capsules EU/1/09/599/009-011 |
Rivastigmine hydrogen tartrate | Sandoz Pharmaceuticals GmbH | — |
| Rivastigmine Sandoz 6 mg hard capsules EU/1/09/599/013-015 |
Rivastigmine hydrogen tartrate | Sandoz Pharmaceuticals GmbH | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 15 August 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.